You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 18, 2025

Drug Price Trends for STOOL SOFTENER-STIM LAX SOFTGL


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for STOOL SOFTENER-STIM LAX SOFTGL

Average Pharmacy Cost for STOOL SOFTENER-STIM LAX SOFTGL

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
STOOL SOFTENER-STIM LAX SOFTGL 70000-0442-01 0.06703 EACH 2025-03-19
STOOL SOFTENER-STIM LAX SOFTGL 70000-0442-01 0.06680 EACH 2025-02-19
STOOL SOFTENER-STIM LAX SOFTGL 70000-0442-01 0.06640 EACH 2025-01-22
STOOL SOFTENER-STIM LAX SOFTGL 70000-0442-01 0.06523 EACH 2024-12-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Stool Softener and Stimulant Laxative Market Analysis and Price Projections

Market Overview

The market for stool softeners and stimulant laxatives is experiencing significant growth, driven by several key factors. Here are some critical aspects to consider:

Growing Demand and Market Size

The global stool softener market is projected to grow substantially in the coming years. By 2028, the market size is expected to reach $2.26 billion, growing at a compound annual growth rate (CAGR) of 7.5% from 2023 to 2028[1][4].

Drivers of the Market

Several factors are driving the growth of the stool softener market:

  • Aging Population: The increasing age of the global population contributes to higher instances of digestive issues, including constipation.
  • Dietary Changes: Changes in diet and lifestyle, such as reduced fiber intake and increased consumption of processed foods, lead to digestive health issues.
  • Increased Public Awareness: Greater awareness about digestive health and the importance of regular bowel movements is driving demand for stool softeners.
  • Higher Healthcare Spending: Increased spending on healthcare, particularly in developed countries, is supporting the growth of the market.
  • Shift to Over-the-Counter Status: Many stool softeners are transitioning from prescription-only to over-the-counter status, making them more accessible to consumers[1][4].

Market Segmentation

By Type

The stool softener market is segmented into different types, including:

  • Liquid: Liquid stool softeners are popular for their ease of use and quick action.
  • Softgel Capsule: Softgel capsules are another common form, known for their convenience and gentle action[1].

By Form

The market is also segmented by form:

  • Medicines: This includes various formulations of stool softeners available in different forms such as tablets, capsules, and liquids.
  • Procedures: While less common, some procedures may involve the use of stool softeners as part of preoperative or postoperative care[1].

By Mode of Administration

  • Oral: The most common mode of administration, oral stool softeners are available in various forms like tablets, capsules, and liquids.
  • Rectal: Rectal administration is less common but still used in certain cases[1][3].

By Availability

  • Over-The-Counter (OTC): Many stool softeners are now available OTC, making them easily accessible to consumers.
  • Prescription: Some stronger formulations may still require a prescription[1].

By End Use

  • Hospitals: Used in hospital settings for patients undergoing surgeries or experiencing digestive issues.
  • Clinics: Clinics also use stool softeners for patient care.
  • Home Care: The majority of stool softeners are used in home care settings due to their OTC status[1].

Key Trends and Innovations

Improvements in Medical Diagnostics and Treatments

Advancements in medical diagnostics and treatments are leading to more effective stool softener formulations. This includes better diagnostic tools to identify gastrointestinal conditions, which in turn drives the demand for stool softeners[1].

Development of Personalized Stool Softener Products

There is a growing trend towards personalized healthcare, including the development of personalized stool softener products tailored to individual needs. This could involve genetic testing or other personalized approaches to digestive health[1].

Innovations in Formulation Technology

Innovations in formulation technology are leading to more effective and convenient stool softeners. For example, the development of effervescent stool softener tablets offers a new and convenient form of administration[1].

Combinatory Products

The trend of combining two or more laxatives into a single product is becoming more popular. This can include combining stool softeners with stimulant laxatives to provide a dual-action effect[3].

Price Projections and Market Dynamics

Current Pricing

The prices of stool softeners vary based on the type, form, and brand. For example, Walgreens Stool Softener Softgels can range from $0.20 to $0.12 per unit, depending on the quantity purchased[2].

Future Pricing Trends

Given the expected growth in the market, prices may stabilize or slightly increase due to higher demand and advancements in formulation technology. However, competition among manufacturers and the shift to OTC status are likely to keep prices relatively affordable for consumers[1][4].

Impact of Macro Economic Scenario

High Inflation

High inflation can impact the pricing of stool softeners by increasing the cost of raw materials and production. However, the essential nature of these products means that demand is likely to remain robust despite price increases[1].

Ukraine-Russia War

Global conflicts can disrupt supply chains and affect the availability of certain ingredients or products. However, the stool softener market is diverse enough to mitigate such impacts to some extent[1].

COVID-19 Impact

The COVID-19 pandemic has accelerated the shift towards home care and self-medication, which has positively impacted the demand for stool softeners. This trend is expected to continue as consumers become more health-conscious[1].

Key Players and Market Competition

The market for stool softeners is competitive, with several key players:

  • AstraZeneca plc
  • Boehringer Ingelheim GmbH
  • Bayer AG
  • GlaxoSmithKline
  • Abbott Laboratories
  • Takeda Pharmaceutical Company
  • Braintree Laboratories
  • Purdue Pharma
  • Sucampo Pharmaceuticals, Inc.[3]

These companies are investing in research and development to create more effective and convenient stool softener products, which is driving innovation and competition in the market.

Consumer Preferences and Product Features

Consumers are increasingly looking for gentle, dependable, and convenient stool softener products. For example, the up&up Stool Softener Softgels from Target are popular due to their ease of use and lack of potentially irritating stimulant laxatives[5].

Key Takeaways

  • The global stool softener market is expected to grow significantly, reaching $2.26 billion by 2028.
  • Key drivers include the aging population, dietary changes, increased public awareness about digestive health, and higher healthcare spending.
  • Innovations in formulation technology and the development of personalized products are trends to watch.
  • The market is segmented by type, form, mode of administration, availability, and end use.
  • Prices are expected to remain relatively stable despite some potential increases due to inflation and other economic factors.

FAQs

What is the projected growth rate of the global stool softener market?

The global stool softener market is expected to grow at a CAGR of 7.5% from 2023 to 2028[1].

What are the main drivers of the stool softener market?

The main drivers include the aging population, dietary changes, increased public awareness about digestive health, higher healthcare spending, and the shift of many stool softeners from prescription-only to over-the-counter status[1].

What types of stool softeners are most common?

The most common types are liquid and softgel capsule forms[1].

How does the macroeconomic scenario impact the stool softener market?

High inflation, global conflicts, and the COVID-19 pandemic can impact the market through supply chain disruptions and changes in consumer behavior, but the essential nature of these products helps maintain demand[1].

Which companies are key players in the stool softener market?

Key players include AstraZeneca plc, Boehringer Ingelheim GmbH, Bayer AG, GlaxoSmithKline, and others[3].

What are the trends in stool softener product development?

Trends include improvements in medical diagnostics and treatments, the development of personalized stool softener products, innovations in formulation technology, and the development of effervescent stool softener tablets[1].

Sources

  1. The Business Research Company, "Stool Softener Global Market Report 2024".
  2. Walgreens, "Stool Softeners".
  3. Business Wire, "Global $8.71 Billion Laxatives Market Analysis & Trends to 2025".
  4. Emergen Research, "Stool Softener Market Size to Reach USD 1.53 Billion in 2027".
  5. Target, "Stool Softener Softgels - 160ct - up&up".

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.